Compare Novavax Inc (NVAX) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Wipro Limited — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while Wipro Limited trades at $1.98 (market cap $19.07B). The key difference: Wipro Limited is far larger — about 14.6× Novavax Inc's market cap, and Wipro Limited pays a 4.4% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | WIT | |
|---|---|---|
Market Cap | $1.31B | $19.07B |
Sector | Health | Technology |
52-Week High | $11.19 | $3.06 |
52-Week Low | $6.22 | $1.78 |
Enterprise Value | $889.30M | $17.16B |
Dividend Yield | — | 4.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
